Search clinical trials for: open access gastroscopy

Total 11744 results

Norwegian Department of Health and Social Affairs

Completed

Drop in Gastroscopy - Experience After 9 Months

Stomach Diseases | Esophageal Diseases | Peptic Ulcer

Norway
University of Washington
National Institute of Nursing Research (NINR)

Recruiting

Lung Transplant READY CF 2: A Multi-site RCT

Cystic Fibrosis

United States
Novartis Pharmaceuticals

Recruiting

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) (OLE)

Hyperlipoproteinemia (a)

Germany
Mayo Clinic

Recruiting

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma in Patients Undergoing Craniotomy

Recurrent Glioblastoma

United States
Levita Magnetics
The Cleveland Clinic

Recruiting

Prospective, Multi-center, Single-arm, Open Label Study Designed to Assess the Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures (MARS GI)

Bariatric Surgery Candidate | Cholelithiases | Other Disease

Chile
VentureMed Group Inc.

Recruiting

FLEX FIRST Registry Research Protocol

Arterial Occlusive Diseases | Fistula | Arteriovenous Fistula | Arteriovenous Graft

United States
University of Guarulhos
ITI Foundation

Recruiting

Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis

Peri-Implantitis

Brazil
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Recruiting

Methods for Increasing Genetic Testing Uptake in Michigan (MiGHT)

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | History of Cancer

United States
Novartis Pharmaceuticals

Recruiting

Secukinumab Open Label Roll-over Extension Protocol

Autoimmunity, Inflammation

China, United States, Spain, Czechia, Mexico, Bulgaria, Colombia, Brazil, Russian Federation, Guatemala, South Africa, Poland, India, Malaysia, Korea, Republic of, Greece
VA Office of Research and Development

Recruiting

Assessing Open Access Audio (OAA)

Hypertension | Diabetes

United States
Lawson Health Research Institute

Not yet recruiting

Validation of a High-Quality Low-Cost Open-Source Electrocardiograph

Medical Devices | Open Access | Low Cost | Electrocardiograph

Canada
University of Colorado, Denver

Recruiting

Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers

Intervertebral Disc Degeneration | Osteoarthritis, Spine

United States
AbbVie

Available

Expanded Access to Bimatoprost (Durysta)

Open-angle Glaucoma
Merit Medical Systems, Inc.

Active, not recruiting

The Merit WRAPSODY AV Access Efficacy Study (WAVE) (WAVE)

Venous Stenosis | Venous Occlusion

United States, United Kingdom, Canada, Brazil
Emalex Biosciences Inc.

Completed

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension (D1AMOND)

Tourette Syndrome in Children | Tourette Syndrome in Adolescence

United States, Poland, France, Canada, Germany
Abramson Cancer Center at Penn Medicine

Completed

A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

Breast Cancer | Colorectal Cancer | Ovarian Cancer

United States
University of Washington
National Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation

Completed

Lung Transplant READY Pilot Study

Cystic Fibrosis

United States
Delcath Systems Inc.

Active, not recruiting

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

Metastatic Uveal Melanoma | Metastatic Ocular Melanoma

United States
Ridgeback Biotherapeutics, LP
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique...

Available

Open-Label Expanded Access for Ebola-Infected Patients to Receive Human mAb Ansuvimab as Therapeutic or for HR PEP

Hemorrhagic Fever, Ebola

Congo, The Democratic Republic of the, Sierra Leone
Incyte Corporation

Active, not recruiting

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Breast Cancer | Pancreatic Cancer | Lung Cancer | Colorectal Cancer (CRC)

United States
University of Arkansas
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Translating the Diabetes Prevention Program (DPP) Lifestyle Intervention to Rural African-American Communities (HEALTHY Ways)

Overweight

United States
Children's Hospital Los Angeles

Completed

Engaging Immigrants in Preventive Parenting Interventions

Parenting | Health Behavior | Social Acceptance
University of Baghdad

Active, not recruiting

Traditional Versus Conservative Access Cavities Cleaning Ability

Root Canal Infection | Root Canal Treatment

Iraq
Hams Hamed Abdelrahman

Completed

Accuracy of Digital Models Using Open-access Software Programs

Accuracy of Digital Dental Model

Egypt
Nektar Therapeutics
Eli Lilly and Company

Terminated

A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) (INSTRUCT-UC)

Colitis, Ulcerative

Australia, India, United States, Korea, Republic of, Hungary, United Kingdom, Japan, Argentina, Belgium, Brazil, Canada, China, Czechia, France, Georgia, Israel, Latvia, Poland, Romania, Russian Federation, Slovakia, Ukraine
BioCryst Pharmaceuticals

Active, not recruiting

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies (APeX-A)

Hereditary Angioedema | HAE

France, North Macedonia, Poland, Korea, Republic of, Slovakia, South Africa, Czechia
Stanford University
University of California, San Francisco

Completed

Evaluation of the Impact of Water Access and Promotion in Parks on Beverage Intake

Obesity

United States
Chiesi Farmaceutici S.p.A.
Chiesi USA, Inc.

Available

Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients

Fabry Disease

United States
VentureMed Group Inc.

Completed

FLEX Vessel Prep Prior to Angioplasty in Native Arteriovenous Fistulae (AVF)

Arteriovenous Fistula Stenosis

United States
Pfizer

No longer available

An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine

Migraine
AI Therapeutics, Inc.

No longer available

An Open-Label, Expanded Access Protocol of LAM-002A in C9ORF72-Associated Frontotemporal Dementia (FTD)

Frontotemporal Dementia
Azienda USL Modena

Completed

1L-PEG-Asc Solution for Bowel Preparation in an "Open Access" Colonoscopy Booking System: Evaluation of Adverse Events

Bowel Preparation

Italy
University of California, San Francisco
American Heart Association; American Medical Association; OCHIN, Inc.; Louisiana...

Active, not recruiting

Improving BP Control in Diverse Populations Using BP MAP (BP MAP)

Hypertension

United States
University Hospital Birmingham NHS Foundation Trust
University of Birmingham; Dystrophic Epidermolysis Bullosa Research Association...

Enrolling by invitation

Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa

Junctional Epidermolysis Bullosa | Laryngo Onycho Cutaneous Syndrome

United Kingdom
Shire

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 3)

Hereditary Angioedema

United States
Shire

Completed

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks (CHANGE 2)

Hereditary Angioedema

United States
Cerus Corporation

Terminated

A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease

Acute Ebola Virus Disease

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

No longer available

Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil

Pulmonary Arterial Hypertension

Brazil
Pfizer's Upjohn has merged with Mylan to form Viatris...

No longer available

Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study (UK 92480)

Pulmonary Arterial Hypertension

India
Pfizer's Upjohn has merged with Mylan to form Viatris...

No longer available

An Open Label Access Study For Subjects Who Completed A1481156

Pulmonary Arterial Hypertension

India
Assiut University

Unknown

Combined Management in ALI ( Image Guided Thrombectomy With Open Transfemoral Access )

Limb Ischemia
Shandong University

Unknown

Intravenous Infusion of Lidocaine in Gastroscopy

Sedation

China
Memorial University of Newfoundland

Completed

A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV (APPROACH)

HIV Infections

Canada
GlaxoSmithKline

Completed

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Asthma

United States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Czechia, Italy, United Kingdom
Eisai Inc.

Terminated

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Refractory Partial Onset Seizures

United States
Celgene

Completed

Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year

Multiple Myeloma

China
Amgen

Completed

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

Bone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer

Spain, Czechia, Peru, Russian Federation, Austria, Lithuania, Poland, South Africa, Italy, Ukraine, Israel, Argentina, Belgium, Brazil, France, Hungary, Japan, Latvia, Panama
Hull University Teaching Hospitals NHS Trust
University of Hull

Withdrawn

Open Versus Percutaneous Insertion of CAPD Catheters

Renal Failure

United Kingdom
Sultan Qaboos University

Completed

Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors (AIPDAP)

Delirium | Anesthesia; Adverse Effect

Oman
Novartis Pharmaceuticals

Completed

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

Neuroendocrine Tumors

Germany

Search clinical trials for: open access gastroscopy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations